In a recent study by Ghiani et al., the potential of an AAZTA-chelated PSMA inhibitor (B28110) radiolabelled with 44Sc ([44Sc]Sc-B28110) was confirmed for the PET imaging of prostate cancer [94]. The gene discussed is FOLH1; the disease is prostate carcinoma.